The Ajay Piramal Group-owned private equity firm, India Venture Advisors, is to launch its second $150-million healthcare fund next year.
After the exit of Subbu Subramaniam from Baring Private Equity Partner India over ?professional differences? with its managing partner Rahul…
3i India Private Ltd, the Indian arm of global private equity major 3i Group Plc, has become the front-runner to…
With the international flow of finance still stagnant, Indian private equity companies are finding their track records under strong scrutiny…
Indage Vinters Ltd, the troubled wine major reeling under pressure as a result of not paying salaries for the last…
They say a good real estate investment is based on the three attributes: location, location and location. Taking the cue,…
Higher valuations quoted by companies have prompted private equity players to opt for the follow-on investments route rather than expand…
Mukesh Ambani owned Reliance Life Sciences (RLS) is on a consolidation mode. The company is in the process..
ICICI Venture, India?s largest private equity firm, has run into difficulties in securing commitments from some key investors for the…
Indian pharma companies continue to be at the receiving end of tough quality scrutiny by drug regulators abroad, the latest…
Jagermeister, a flagship product of international major Mast-J?germeister AG, is strengthening its position in India. The herbal liqueur brand, introduced…
The search for innovative drug molecules and better technologies by pharmaceutical MNCs is expected to offer a windfall for the…
With the USFDA?s raids at Sun Pharma?s facilities in the US, the list of the Indian pharma majors under the…
Astellas Pharma, the second largest pharmaceutical company in Japan, is eyeing marketing alliances in Indian pharmaceuticals sector.
The exits made by major private equity players such as ChrysCapital and IL&FS Investment Managers Ltd from their investments in…
Private Equity and Venture Capital investors, who have invested over $2 billion into Healthcare & Life Sciences companies in India…
An internal investigation into an alleged misappropriation of funds at Diageo India is widening, with the axing of five more…
Tough competition from peers and global generic firms is cluttering up the space for Indian companies in the off patent…
